Celebrity Inventors
Glam girl Heddy Lamar may have used her good looks to good effect on the silver screen, but she put her smarts to better use as an inventor. During World War II, she co-patented a frequency-switching system for torpedo guidance that was considered years ahead of its time.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8187639 | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in ... | 05/29/2012 |
| 8182841 | Amniotic membrane preparations and purified compositions and anti-inflammation methods Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in ... | 05/22/2012 |
| 8182840 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in ... | 05/22/2012 |
| 8153162 | Purified amniotic membrane compositions and methods of use Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in ... | 04/10/2012 |
| 8105634 | Umbilical cord biomaterial for medical use The present invention provides a biomaterial comprising a mammalian umbilical cord membrane. The biomaterial can additionally comprise Wharton's jelly and/or one or more umbilical cord vessels. The biomaterial is preferably dry, and can be flat, tubular, or shaped t... | 01/31/2012 |
| 8071135 | Placental tissue compositions The present invention encompasses compositions, including solutions, gels, and pastes, manufactured from amniotic membrane, umbilical cord membrane, or both. The present invention also encompasses methods of making such compositions, and methods of using the composi... | 12/06/2011 |
| 7311904 | Tissue matrices comprising placental stem cells, and methods of making the same A method of manufacturing a tissue matrix for implantation into a patient is disclosed. The method sets forth collecting embryonic stem cells from a placenta which has been treated to remove residual cord blood and seeding the collected stem cells onto or into a tis... | 12/25/2007 |
| 7311905 | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells The present invention provides compositions and methods of using embryonic-like stem cells that originate from a post-partum placenta with conventional cord blood compositions or other stem or progenitor cells. The embryonic-like stem cells can be used alone or in a... | 12/25/2007 |
| 6660305 | Composition for stimulating the synthesis of the melanic pigment and process for obtaining it This invention relates to the field of human medicine, more specifically to dermatology, and in particular to a composition developed for the stimulation of the synthesis of the melanic pigment of the skin, therefore useful for the treatment of vitiligo. ... | 12/09/2003 |
| 6638520 | Structures and methods for promoting vascularization One aspect of the present invention provides implantable medical devices that comprise: (a) a device body; and (b) a surface layer attached to at least a portion of the device body, the surface layer comprising: (1) a surface layer body that defines an in... | 10/28/2003 |
| 6605275 | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood The present invention relates to hematopoietic stem and progenitor cells of neonatal or fetal blood that are cryopreserved, and the therapeutic uses of such stem and progenitor cells upon thawing. In particular, the present invention relates to the therap... | 08/12/2003 |
| 6277828 | Pharmaceutical formulations of nerve growth factor Stable, aqueous pharmaceutical formulations of human nerve growth factor (NGF) in aqueous isotonic solutions, buffered to maintain the pH from about 4.5 to about 6.0, and optionally containing a carrier such as human serum albumin are provided. Also provi... | 08/21/2001 |
| 6183749 | Dietary supplement containing herbal extracts which promotes healthy hair growth on the scalp A composition of a dietary supplement comprising MAMMALIA PLACENTA prepared from the placenta of a mammal, FRUCTUS LIGUSTRI LUCIDI, SALVIAE MILTIORRHIZAE, PAEONIAE RUBRA, CINNAMOMI CASSIAE, MOUTAN RADICIS, and ALISMATIS PLANTAGO-AQUATICA. For increased be... | 02/06/2001 |
| 5969125 | Secreted proteins and polynucleotides encoding them Novel polynucleotides and the proteins encoded thereby are disclosed.... | 10/19/1999 |
| 5707657 | Food supplement containing animal fetal mesenchymal matter and animal fetal organ extracts A food supplement comprises isolated animal mesenchymal matter of fetal origin and extracts of animal organs of fetal origin, the mesenchymal matter consisting of a network of loose connective tissue and the food supplement being free of chemical preserva... | 01/13/1998 |
| 5690966 | Process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin-like constituent peptides useful for the treatment of vitiligo A process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin-like peptides useful for the treatment of vitiligo is disclosed.... | 11/25/1997 |
| 5558875 | Method of preparing collagenous tissue A process of preparation of a collagenous prosthesis for removing cell membrane proteins from a biological collagenous tissue and preserving elasticity of the collagenous prosthesis comprises the following steps: (a) soaking the tissue in an organic deter... | 09/24/1996 |
| 5512304 | Method of preparing a thromboplastin extract A thromboplastin extract including an aqueous thromboplastin extract of a powdered thromboplastin source including a metal ion chelator. A thromboplastin reagent for use in blood coagulation tests, the thromboplastin reagent includes the extract and calci... | 04/30/1996 |
| 5391380 | Thromboplastin extract, reagent, and preparation thereof A thromboplastin extract including an aqueous thromboplastin extract of a powdered thromboplastin source including a metal ion chelator. A thromboplastin reagent for use in blood coagulation tests, the thromboplastin reagent includes the extract and calci... | 02/21/1995 |
| 5324822 | Method of isolating a CA 195-like immunoreactive antigen from human amniotic fluid A method of isolation of a material with similar immunological properties to CA-195 from human amniotic fluid has been disclosed. This material can be substituted for CA-195 in many processes, for example in the preparation of analytical control materials... | 06/28/1994 |
| 5296467 | Composition comprising an anticoagulant Pharmaceutical compositions which consist essentially of a vascular anticoagulant annexine, Ca2+, Zn2+, and a pharmaceutically acceptable carrier are disclosed. Also disclosed are processes for preparing such pharmaceutical compositi... | 03/22/1994 |
| 5254350 | Method of preparing a thromboplastin extract A process for preparing a thromboplastin extract including extracting a powdered thromboplastin source in an aqueous solution having a metal ion chelator, and separating the powder in solution into sedimented powder and supernatant thromboplastin extract ... | 10/19/1993 |
| 5210185 | Human nerve growth factor The present invention is directed to a method for the isolation of Human Nerve Growth Factor (HNGF) from human placenta. More particularly, the invention is directed to the method of isolation of the ଲ-subunit of Human Nerve Growth Factor and Compos... | 05/11/1993 |
| 5180743 | Anti-inflammatory and analgesic compounds, related compositions and methods for preparation and use thereof This application relates to an anti-inflammatory, immunosuppressive and analgesic composition, a method for its preparation, a pharmaceutical composition including it and a method of treating auto-immune diseases. The anti-inflammatory, immunosuppressive ... | 01/19/1993 |
| 5175005 | Method of controlling lung tumor cell metastasis A method of controlling tumor cell metastasis comprising administering to a human a therapeutically effective amount of a ribonuclease inhibitor.... | 12/29/1992 |
| 5169835 | Pregancy specific proteins applications At least seven genes have been identified which encode proteins generally identified as pregnancy specific protein (SP1), also known as pregnancy specific beta glycoprotein (PSBG). These genes have been found using human placental SP1 labelled cDNA in a n... | 12/08/1992 |
| 5149535 | Process for the modification of whey Method for the manufacture of modified whey with the assistance of lactic acid bacteria for use in manufacturing washing-active substances, as well as, cosmetic and pharmaceutical products, including the step of at least partially freeing the way of lacto... | 09/22/1992 |
| 5139783 | Process for the preparation of alginate capsules, apparatus for producing said capsules and cosmetic compositions containing said capsules A process for producing alginate capsules comprises slowly introducing an aqueous alginate solution into crosslinking solution of a polyvalent metal salt. The aqueous alginate solution has mannuronic units (M) and guluronic units (G) in a molar ratio betw... | 08/18/1992 |
| 5055485 | Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides A process of inactivating infectious viruses in a cell-containing or a protein-containing composition containing such viruses, comprising contacting such composition with an effective amount of at least one aryl diol epoxide of the formula ##STR1## ... | 10/08/1991 |
| 5019556 | Inhibitors of angiogenin An inhibitor of angiogenin and method of use of the inhibitor, wherein the inhibitor inhibits the angiogenic activity of angiogenin. The inhibitor is dispensed at a suitable concentration within a physiologically compatable medium, suitable for administra... | 05/28/1991 |
| 5002071 | Injectable soft tissue augmentation materials from the placenta and their method of manufacture Disclosed is a soft tissue augmentation material from human placenta homogenized to pass through a surgical needle, preferably a 30 gauge surgical needle, and cross-linking collagen molecules of the material by gamma irradiation. Also disclosed are method... | 03/26/1991 |
| 4996057 | Composition for locally treating the epidermis, especially the scalp The object of the invention is a composition for the local treatment of the epidermis comprising at least two active constituents, characterized in that one of these constituents is a product resulting from the condensation of N-methyl-p-methoxyphenethyla... | 02/26/1991 |
| 4985255 | External preparations of melanogenesis-inhibitory agent External preparations of 1 melanogenesisinhibitory agent contain, as active ingredients, a placental extract of pregnant cows and kojic acid or a derivative thereof. The placental extract of pregnant cows is a very effective melanogenesis-inhibitory subst... | 01/15/1991 |
| 4906461 | Hair treatment composition A hair treatment which replaces properties of hair which has been treated with a chemical treatment such as perming, coloring or straightening is disclosed. The present invention may be formulated with a neutral base solution for use with present cream mo... | 03/06/1990 |
| 4876241 | Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants A method of inactivating pathogens in proteinaceous biological and pharmaceutical products which comprises: mixing the product in an aqueous solution with one or more primary stabilizers selected from the group consisting of sugars and sugar alcohols and ... | 10/24/1989 |
| 4873222 | Placenta-derived anticoagulating substance A human placenta-derived antiocoagulating substance is prepared by homogenizing a human plancenta, subjecting the resulting homogenate to centrifugal separation, extracting the thus-obtained sediment with a chelating agent, and then separating and purifyi... | 10/10/1989 |
| 4748156 | Thrombin-binding substance and process for preparing the same A novel thrombin-binding substance having the characteristics of (a) molecular weight: 47,000&#b1;6,000 in reduced condition and 38,000&#b1;6,000 in unreduced condition, (b) isoelectric point: pH 4.9-5.7, (c) affinity: strong affinity to thrombin, (d) act... | 05/31/1988 |
| 4696813 | Melanin inhibiting cosmetic composition Placenta extracts and kojic acid or kojic acid derivatives are formulated into cosmetic bases to make cosmetic compositions. The cosmetic compositions exhibit an enhanced whitening effect for the skin due to the action of the placenta extract and kojic ac... | 09/29/1987 |
| 4673733 | Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents A method for treating a biological or pharmaceutical product to inactivate viruses and pyrogens therein comprising the steps of adsorbing said product onto a solid phase; treating the adsorbed product with a virus or pyrogen inactivating agent; separating... | 06/16/1987 |
| 4638050 | Thrombin-binding substance and process for its production A thrombin-binding substance derived from human tissue and having the characteristics of (a) molecular weight: 88,000&#b1;20,000 in reduced condition and 71,000&#b1;20,000 in unreduced condition; (b) isoelectric point: p H 4.2&#b1;0.5; (c) affi... | 01/20/1987 |
